Thailand pharmaceutical market update, 2013

23/05/2013

Ames Gross

Ames Gross of Pacific Bridge Medical provides an overview of the pharmaceutical market in Thailand. Thailand's pharmaceutical market was worth $4.4 billion in 2012, making it larger than any other market...

Promoting transparency to avoid costly healthcare mistakes – the CHEER…

22/05/2013

Donald Husereau

Donald Husereau highlights the benefits of the recent CHEERS guidelines to biomedical publishing. More than ever, rising healthcare costs have led to the need for good healthcare decisions. Yet the information...

Promoting research, innovation and competition: the reform of the clin…

22/05/2013

Catherine McLoughlin

With changes proposed to the clinical trials regime in the EU, we look at the principal changes being considered and assess their potential impact on the conduct of research and...

How doctors prefer to engage with pharma: part three

21/05/2013

Doctor C

 In part of three of this series, Hannah Blake interviews an oncologist (who will be referred to as Doctor C) about his thoughts on the interaction between physicians and pharma. (Continued...

FDA panel recommends Merck’s insomnia drug for approval

23/05/2013

Hannah Blake

An FDA advisory panel has voted in favour of Merck & Co's experimental insomnia drug, saying that it is safe and effective for elderly patients at the lower of two...

Novo acquires Xellia Pharma for $700m

22/05/2013

Hannah Blake

Novo A/S has announced its acquisition of Xellia Pharmaceuticals for US $700 million. Novo A/S is the holding company of the Novo Group, which is the major shareholder in Danish pharma...

GSK given $200m to develop antibiotics

22/05/2013

Hannah Blake

The US Department of Health and Human Services (HHS) has entered into a first-of-its-kind collaboration with GSK, whereby the HHS' Biomedical Advanced Research and Development Authority (BARDA) provide GSK with...

Phase 2 trials show Sanofi, Regeneron drug reduces risk of asthma atta…

21/05/2013

Hannah Blake

Postive phase 2 clinical trial data of Sanofi and Regeneron's asthma treatment, dupilumab, have today been published in the New England Journal of Medicine. The study found that dupilumab (Sis...

Open access in medical journals - interv…

Executive perspectives: Bruno Strigini

Doctors hold the key to understanding pa…

Carly Brown

Pharma is recognising the increasing importance of the patient voice in providing feedback on how medicines are utilised in a real-world setting and the impact they are having on outcomes....

Outcomes shape the new payer networks fo…

Marcelo Fantoni

The definition of the payer and the way in which healthcare spending decisions are made is changing, as complex networks of payers and clinicians become the new stakeholders with which...

Publishing white papers on pharmaphorum

Paul Tunnah

As a new feature on pharmaphorum, we unveil pharmaceutical industry white papers as part of our media section. Download this one page document to understand how to publish your deep...